@article {JintaP2961, author = {Torahiko Jinta and Naoki Nishimura and Sachiko Ohde and Seishiro Marukawa and Masayuki Suzukawa and Naohiko Chohnabayashi}, title = {Clinical application of non-invasive positive-pressure ventilation in patients with community-acquired pneumonia}, volume = {44}, number = {Suppl 58}, elocation-id = {P2961}, year = {2014}, publisher = {European Respiratory Society}, abstract = {Background: Non-invasive positive-pressure ventilation (NPPV) is often used for respiratory failure. However, there are few evidences to suggest its use in patients with community-acquired pneumonia (CAP).Purpose: To demonstrate the actual status of the usage of NPPV in CAP patients in Japan.Methods: We conducted a multicenter retrospective survey on the status of use of NPPV in patients with CAP between April 2012 and March 2013. Data on patients with CAP ventilated by NPPV were collected, and we recorded the clinical setting, severity of CAP, and clinical course.Results: In 187 patients, 11 were eliminated because of unknown clinical course. Of the remaining 176 patients, 129 were male with a median age of 79 (20 to 101) years and median duration of NPPV treatment was 6 (1 to 379) days. Ninety-seven patients were removed from NPPV successfully and 16 were intubated (11 patients died after intubation). Sixteen patients continued NPPV at home because of difficulty in weaning from ventilatory support. Forty-seven patients died during treatment by NPPV; these patients preferred not to be intubated.Conclusions: NPPV for community-acquired pneumonia is a potent therapeutic tool for those patients who do not wish to receive invasive treatment.}, issn = {0903-1936}, URL = {https://erj.ersjournals.com/content/44/Suppl_58/P2961}, eprint = {https://erj.ersjournals.com/content}, journal = {European Respiratory Journal} }